Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Talinolol proves effective in addition to conventional therapy in CHF

July 15, 1999

Licensing opportunity from NIH: antisense oligonucleotides for treating restenosis

July 15, 1999

Satellite symposium on antiarrhythmics underlines particular promise of dronedarone

July 14, 1999

Licensing opportunity from NIH: method of preventing or reducing ischemic injury of the heart

July 14, 1999

INO-5042: new agent for venous insufficiency proves effective in various animal models

July 12, 1999

New orally bioavailable salt of ET antagonist prepared by SmithKline Beecham

July 12, 1999

Digital Gene Technologies and Recordati reach milestone in atherosclerosis agreement

July 12, 1999

Delta-opioid receptor activation as preconditioning, similar to natural hibernation

July 12, 1999

Phase III combination trial begins for ranolazine in stable angina

July 9, 1999

ACE inhibitor quinaprilat stimulates angiogenesis in vivo

July 9, 1999

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...